Popular diabetes and weight loss drugs such as Ozempic and Wegovy have been linked to a slightly increased risk of a rare condition that can cause sudden, potentially permanent vision loss. Although ...

Eli Lilly’s latest weight loss drug candidate, retatrutide, is already being talked about as a potential game changer in ...

In the first head-to-head trial of Ozempic versus Eli Lilly's new "King Kong" drug retatrutide, the next-generation drug led ...

Once-weekly retatrutide induced greater declines in HbA1c and body weight than Ozempic 2 mg for adults with type 2 diabetes, ...

By Sriparna Roy Oct 28 (Reuters) - Eli Lilly said on Wednesday its experimental next-generation obesity drug, retatrutide, ...

Eli Lilly’s next generation weight loss drug, known as retatrutide, was shown to provide more than double the weight loss of ...

Lilly reports that retatrutide achieved greater weight loss and blood sugar reduction than Ozempic 2 mg in an 80-week type 2 ...

In a head-to-head trial, participants with type 2 diabetes lost more than twice as much weight with retatrutide as with Ozempic and had a greater reduction in A1c.

In a recent head-to-head trial, Eli Lilly's 'Godzilla' drug retatrutide resulted in an average of 20.9% weight loss over 80 ...

"Ozempic feet" is an informal term describing heel pain and foot discomfort caused by the rapid loss of protective subcutaneous fat padding in the feet during GLP-1 weight loss therapy. Rapid body fat ...

Renée Fabian is Lead Editor for Pet Health at Forbes Advisor. She has over 10 years experience as a journalist and editor covering pet and human health topics. Renée previously worked as senior pet ...